Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001209191-21-038328
Filing Date
2021-06-04
Accepted
2021-06-04 17:27:19
Documents
1
Period of Report
2021-06-02

Document Format Files

Seq Description Document Type Size
1 FORM 4 SUBMISSION doc4.html 4  
1 FORM 4 SUBMISSION doc4.xml 4 3368
  Complete submission text file 0001209191-21-038328.txt   5045
Mailing Address 5 SYLVAN WAY SUITE 300 PARSIPPANY NJ 07054
Business Address 5 SYLVAN WAY SUITE 300 PARSIPPANY NJ 07054 973-254-3560
Pacira BioSciences, Inc. (Issuer) CIK: 0001396814 (see all company filings)

EIN.: 510619477 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address C/O PACIRA BIOSCIENCES, INC. 5 SYLVAN WAY, SUITE 300 PARSIPPANY NJ 07054
Business Address
Manning Donald C. (Reporting) CIK: 0001775268 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-35060 | Film No.: 21997529